News
DSNKY
18.30
-0.54%
-0.10
Nuvation Bio gains global rights to brain cancer therapy from Daiichi Sankyo
Seeking Alpha · 3d ago
*Nuvation Bio Now Has Global Development and Commercialization Rights for Safusidenib >NUVB
Dow Jones · 3d ago
*Nuvation Bio Announces Acquisition of Japan Rights to Safusidenib From Daiichi Sankyo
Dow Jones · 3d ago
*Nuvation Bio: Agreement Provides Ownership of Global Clinical Development Program, Inclusive of Clinical Trials, Past and Current Data Generation, and Future Publications >NUVB
Dow Jones · 3d ago
Press Release: Nuvation Bio Announces Acquisition of Japan Rights to Safusidenib from Daiichi Sankyo
Dow Jones · 3d ago
Weekly Report: what happened at DSNKY last week (0323-0327)?
Weekly Report · 5d ago
Weekly Report: what happened at DSNKY last week (0316-0320)?
Weekly Report · 03/23 09:21
Weekly Report: what happened at DSNKY last week (0309-0313)?
Weekly Report · 03/16 09:20
Highest and lowest quant-rated healthcare stocks above $10B cap after earnings season
Seeking Alpha · 03/14 14:35
Weekly Report: what happened at DSNKY last week (0302-0306)?
Weekly Report · 03/09 09:21
Daiichi Sankyo And AstraZeneca's ENHERTU Granted FDA Priority Review As Post-Neoadjuvant Treatment For HER2 Positive Early Breast Cancer, With PDUFA Date Of July 7, 2026
Benzinga · 03/09 06:46
Weekly Report: what happened at DSNKY last week (0223-0227)?
Weekly Report · 03/02 09:21
New Strong Sell Stocks for February 25th
NASDAQ · 02/25 09:34
Daiichi Sankyo: Hit On Multiple Fronts, But Shares Look Undervalued
Seeking Alpha · 02/24 10:00
Weekly Report: what happened at DSNKY last week (0216-0220)?
Weekly Report · 02/23 09:21
Daiichi Sankyo And AstraZeneca's ENHERTU Gains European Medicines Agency Validation For HER2 Positive Early Breast Cancer After Showing 53% Reduced Risk Of Disease Recurrence
Benzinga · 02/19 08:01
Weekly Report: what happened at DSNKY last week (0209-0213)?
Weekly Report · 02/16 09:21
Weekly Report: what happened at DSNKY last week (0202-0206)?
Weekly Report · 02/09 09:21
Astra wins FDA priority review for Daiichi’s Datroway; denied approval for lupus therapy
Seeking Alpha · 02/03 13:19
Weekly Report: what happened at DSNKY last week (0126-0130)?
Weekly Report · 02/02 09:21
More
Webull provides a variety of real-time DSNKY stock news. You can receive the latest news about Daiichi Sankyo through multiple platforms. This information may help you make smarter investment decisions.
About DSNKY
Daiichi Sankyo Co Ltd is a Japan-based company mainly engaged in the manufacture and sale of pharmaceuticals. The Company is involved in the research, development, manufacture and sale of pharmaceuticals, as well as the provision of intermediates and basic materials for pharmaceutical producing in Japan, the United States, Europe and other markets. The Company is also engaged in the research, development, manufacture and sale of over-the-counter drugs and vaccines, the provision of administrative services such as human resources and accounting services, real estate leasing and insurance agency business.